• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

七个中国家族的 von Hippel-Lindau 病中 VHL 基因的种系突变。

Germline mutations of the VHL gene in seven Chinese families with von Hippel-Lindau disease.

机构信息

Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, PR China.

出版信息

Int J Mol Med. 2012 Jan;29(1):47-52. doi: 10.3892/ijmm.2011.808. Epub 2011 Oct 4.

DOI:10.3892/ijmm.2011.808
PMID:21972040
Abstract

Von Hippel-Lindau (VHL) disease is a hereditary tumor syndrome caused by mutations or deletions within the VHL tumor-suppressor gene, but VHL germline mutations in the Chinese have rarely been studied. To investigate the genetic profile of VHL mutations in the Chinese population, we evaluated the clinical characteristics of seven Chinese families suffering from VHL disease and determined the particular germline mutations in their VHL genes. Direct sequencing and real-time quantitative PCR was carried out. Disease-associated genetic abnormalities were identified in all of the seven families examined. Two novel intragenic germline mutations (645 G insertion and 417 G deletion) were identified and are reported for the first time. Partial VHL gene deletions in exon 1 were found in two of the seven families. Three clinically asymptomatic mutation carriers were also identified. The spectrum of VHL gene abnormalities in our group is distinct from that observed in North America, Europe and Japan. These mutations are also different from those previously identified in other Chinese VHL patients. Future meta-analysis will provide greater perspective on the Chinese VHL genetic profile. VHL gene screening can play a key role in identifying asymptomatic patients who are carriers of VHL-predisposing genetic abnormalities.

摘要

希佩尔-林道(VHL)病是一种遗传性肿瘤综合征,由 VHL 肿瘤抑制基因中的突变或缺失引起,但中国人的 VHL 种系突变很少被研究过。为了研究中国人 VHL 基因突变的遗传特征,我们评估了 7 个患有 VHL 病的中国家庭的临床特征,并确定了他们 VHL 基因中的特定种系突变。进行了直接测序和实时定量 PCR。在所有检查的 7 个家庭中都发现了与疾病相关的遗传异常。鉴定出了两个新的基因内种系突变(645G 插入和 417G 缺失),这是首次报道。在 7 个家庭中的 2 个发现了外显子 1 中的部分 VHL 基因缺失。还发现了 3 个临床无症状的突变携带者。我们组的 VHL 基因突变谱与在北美、欧洲和日本观察到的不同。这些突变也与其他中国 VHL 患者以前鉴定的突变不同。未来的荟萃分析将提供更广泛的视角来研究中国 VHL 的遗传特征。VHL 基因筛查可以在识别携带 VHL 易感性遗传异常的无症状患者方面发挥关键作用。

相似文献

1
Germline mutations of the VHL gene in seven Chinese families with von Hippel-Lindau disease.七个中国家族的 von Hippel-Lindau 病中 VHL 基因的种系突变。
Int J Mol Med. 2012 Jan;29(1):47-52. doi: 10.3892/ijmm.2011.808. Epub 2011 Oct 4.
2
Germline VHL gene mutations in Hungarian families with von Hippel-Lindau disease and patients with apparently sporadic unilateral pheochromocytomas.患有冯·希佩尔-林道病的匈牙利家族及明显散发的单侧嗜铬细胞瘤患者的种系VHL基因突变
Eur J Endocrinol. 2009 Sep;161(3):495-502. doi: 10.1530/EJE-09-0399. Epub 2009 Jul 2.
3
Germline mutations in the von Hippel-Lindau disease (VHL) gene in mainland Chinese families.中国大陆家族中冯·希佩尔-林道病(VHL)基因的种系突变。
J Cancer Res Clin Oncol. 2008 Nov;134(11):1211-8. doi: 10.1007/s00432-008-0399-x. Epub 2008 Apr 30.
4
[Large germline deletion of the VHL gene in Chinese families with von Hippel-Lindau syndrome].[中国冯·希佩尔-林道综合征家系中VHL基因的大片段种系缺失]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009 Oct;26(5):539-41. doi: 10.3760/cma.j.issn.1003-9406.2009.05.014.
5
Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma.墨西哥小脑成血管细胞瘤患者的希佩尔-林道病种系突变
J Neurosurg. 2006 Mar;104(3):389-94. doi: 10.3171/jns.2006.104.3.389.
6
[Germ line mutations in Chinese kindreds with von Hippel-Lindau syndrome].[中国冯·希佩尔-林道综合征家系中的生殖系突变]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007 Apr;24(2):124-7.
7
VHL Germline Mutations in Argentinian Patients with Clinical Diagnoses or Single Typical Manifestations of Type 1 von Hippel-Lindau Disease.阿根廷临床诊断为1型希佩尔-林道病或具有单一典型表现患者的VHL基因种系突变
Genet Test Mol Biomarkers. 2016 Dec;20(12):771-776. doi: 10.1089/gtmb.2016.0204. Epub 2016 Sep 12.
8
Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene.冯·希佩尔-林道病肿瘤抑制基因种系突变检测的改进
Hum Mutat. 1998;12(6):417-23. doi: 10.1002/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K.
9
Genetic study of a large Chinese kindred with von Hippel-Lindau disease.对一个患有希佩尔-林道病的大型中国家系的遗传学研究。
Chin Med J (Engl). 2004 Apr;117(4):552-7.
10
Family history of von Hippel-Lindau disease was uncommon in Chinese patients: suggesting the higher frequency of de novo mutations in VHL gene in these patients.中国人患 von Hippel-Lindau 病的家族史罕见:提示这些患者中 VHL 基因突变的频率更高。
J Hum Genet. 2012 Apr;57(4):238-43. doi: 10.1038/jhg.2012.10. Epub 2012 Feb 23.

引用本文的文献

1
The genetic differences between types 1 and 2 in von Hippel-Lindau syndrome: comprehensive meta-analysis.Ⅰ型和Ⅱ型 von Hippel-Lindau 综合征的基因差异:综合荟萃分析。
BMC Ophthalmol. 2024 Aug 13;24(1):343. doi: 10.1186/s12886-024-03597-1.
2
Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: not a needle in a haystack.冯·希佩尔-林道病中的嗜铬细胞瘤和副神经节瘤:并非大海捞针。
Endocr Connect. 2021 Oct 27;10(11):R293-R304. doi: 10.1530/EC-21-0294.
3
Glucagon receptor gene mutations with hyperglucagonemia but without the glucagonoma syndrome.
伴有高胰高血糖素血症但无胰高血糖素瘤综合征的胰高血糖素受体基因突变
World J Gastrointest Surg. 2015 Apr 27;7(4):60-6. doi: 10.4240/wjgs.v7.i4.60.
4
Clinical and genetic investigation of a multi-generational Chinese family afflicted with Von Hippel-Lindau disease.一个患有冯·希佩尔-林道病的中国多代家族的临床与遗传学调查。
Chin Med J (Engl). 2015 Jan 5;128(1):32-8. doi: 10.4103/0366-6999.147802.
5
Von Hippel-Lindau disease type 2 in a Chinese family with a VHL p.W88X truncation.一个中国家庭的 2 型冯·希佩尔-林道病,带有 VHL p.W88X 截断突变。
Endocrine. 2015 Feb;48(1):83-8. doi: 10.1007/s12020-014-0368-x. Epub 2014 Jul 29.
6
Epidemiological study of a von Hippel-Lindau family in northwest China.中国西北地区 von Hippel-Lindau 家族的流行病学研究。
Front Med. 2013 Sep;7(3):378-85. doi: 10.1007/s11684-013-0276-0. Epub 2013 Jul 5.